U.S. Media Stock News

Wondering if Range Resources at around US$40.69 is giving you fair value for the risk you are taking, or if the market is mispricing the story? The stock has seen mixed recent returns, with a 7 day return of an 8.0% decline and a 30 day return of a 6.5% decline, set against a 15.3% return year to date and 23.2% over the last year. Recent attention on Range Resources has centered on its share price performance over the past few years, with total returns over 3 years and 5 years that are well...

Rezolve AI, listed as NasdaqGM:RZLV, has reopened merger talks with Commerce.com after a previously rejected takeover bid. The companies have scheduled a joint investor call to outline plans for a potential AI native commerce platform. This marks a shift from earlier public disputes toward a more collaborative discussion on a possible combination. Rezolve AI focuses on applying artificial intelligence to commerce, aiming to help merchants and enterprises automate and personalize how...

The United States market has recently experienced a robust climb, with a 4.4% increase in the last week and an impressive 32% rise over the past year, while earnings are projected to grow by 16% annually. In this context of strong market performance, identifying stocks that are estimated to be below their fair value can present opportunities for investors seeking potential growth at reasonable prices.

Oklo (OKLO) is reshaping its leadership by adding four experienced directors and a Lead Independent Director, and by shifting its Chief Technology Officer into an advisory role to support its power, fuel, and isotope ambitions. See our latest analysis for Oklo. Those boardroom changes come after a volatile period for investors. The share price is up 8.6% over the last day and 25.7% over the week. However, the 90 day share price return shows a 39% decline, which contrasts with a very large 3...

If you are wondering whether Novo Nordisk's current share price still reflects its long term potential, the key question is how its fundamentals stack up against that price. The stock last closed at US$39.32, with returns of 6.5% over 7 days and 3.6% over 30 days, but a 24.9% decline year to date and a 37.0% decline over the past year, which may suggest that expectations and perceived risk have shifted. These moves have put a spotlight on Novo Nordisk in broader market commentary and...

Mueller Water Products Snapshot After Recent Share Performance Mueller Water Products (MWA) has drawn attention after a recent share price of $30.19, with the stock showing positive total returns over the month, past 3 months, year to date, and the past year. With a market value of about $4.75b and annual revenue of $1,443.6m, the company operates across Water Flow Solutions and Water Management Solutions, serving municipal and construction related water infrastructure needs. See our latest...

Uber Technologies (NYSE:UBER) is committing over $10b to autonomous vehicle purchases and equity investments in AV developers. The company plans to acquire at least 35,000 autonomous vehicles and expand its robotaxi ambitions. Uber is investing in Lucid and UK based Wayve as part of this broader autonomous mobility push. The move marks a shift away from Uber's traditional asset light model toward operating larger in house AV fleets. Uber enters this phase of heavier capital commitment with...

Over the last 7 days, the United States market has risen by 4.4%, contributing to a remarkable 32% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often reflect strong confidence from those most familiar with their operations and potential.

If you are wondering whether Ally Financial at around US$42.57 represents fair value or a potential opportunity, this article explains what the recent share price moves may indicate about the price you are paying. The stock has returned 5.7% over the last week and 17.8% over the last month. The 1 year return is 36.0%, while the year to date return reflects a 7.0% decline. Recent coverage of Ally Financial has focused on how its share price performance compares with the broader Consumer...

Over the last 7 days, the United States market has risen by 4.4%, and in the past year, it has climbed an impressive 32%, with earnings expected to grow by 16% annually. While penny stocks might seem like a relic from earlier market times, they continue to represent smaller or less-established companies that can offer significant value when chosen wisely. By focusing on those with strong financials and clear growth potential, investors can uncover opportunities in these niche stocks that may...

The United States market has shown impressive momentum, climbing 4.4% in the last week and rising 32% over the past year, with earnings projected to grow by 16% annually in the coming years. In this dynamic environment, identifying stocks with strong fundamentals and growth potential can uncover promising opportunities for investors seeking to capitalize on these positive trends.

Context for General Electric’s Recent Share Performance General Electric (GE) has drawn fresh attention after recent share price moves, with the stock up about 2% over the past day, 10% over the past week, and 6% over the past month. Investors are reassessing what the current valuation implies for a business generating US$45.9b in revenue and US$8.6b in net income. See our latest analysis for General Electric. Recent trading suggests momentum has been choppy rather than one way, with short...

Ondas (ONDS) is back in focus after a cluster of contract wins tied to military engineering vehicles, airspace security for the 2026 FIFA World Cup, and a large-scale demining program, alongside a new European drone defense venture. See our latest analysis for Ondas. Despite the flurry of contract announcements, Ondas' recent share price return has been weak. The 30 day share price return is 7.48%, and the 90 day share price return is a 30.68% decline, while the 1 year total shareholder...

Putting W. P. Carey in context for income focused investors W. P. Carey (WPC) sits in the net lease REIT space with a portfolio of 1,682 single tenant properties and US$1.7b in annual revenue, drawing from industrial, warehouse, retail and investment management activities. For investors watching long term performance, WPC shows a total return of 25.0% over the past year and 32.4% over five years, with a year to date total return of 10.4% as of the latest close. See our latest analysis for W...

Wondering whether Selective Insurance Group at around US$80.90 is starting to look interesting on value, or still has more risk than reward baked into the price. The stock is up 2.1% over the last week and 5.9% over the last month, although year to date it shows a 3.1% decline and the 1 year return sits at a 6.5% loss, with a 3 year return of 11.4% loss and a 5 year return of 14.4% gain. Recent coverage has focused on the share price performance and how it compares with the wider insurance...

With no single headline event moving Diamondback Energy (FANG) today, investors are instead weighing its recent share performance, current valuation metrics, and the scale of its Permian focused oil and gas business. See our latest analysis for Diamondback Energy. At a share price of US$186.51, Diamondback’s 90 day share price return of 23.66% and year to date share price return of 22.43% contrast with a 1 year total shareholder return of 47.14%, suggesting momentum has been building over...

Acadia Pharmaceuticals has now made DAYBUE STIX, a dye- and preservative-free powder formulation of trofinetide for oral solution, broadly available in the US for treating Rett syndrome in adults and children aged two and older, following its FDA approval in December 2025 and confirmation of bioequivalence to the original DAYBUE oral solution. The launch not only offers caregivers greater flexibility in dose volume and taste, but also comes as Rett experts increasingly view trofinetide as...

If you are wondering whether Copa Holdings at around US$120.90 still offers value or if the easier gains have already been realized, this breakdown can help you frame what the current share price might be implying. The stock returned 8.4% over the last week, 9.5% over the last month, is roughly flat year to date with a 0.8% decline, and sits on a 42.6% return over the last year. This provides useful context before comparing price to fundamentals. Recent coverage has focused on Copa Holdings...

Wondering if Labcorp Holdings at around US$268.87 is still good value or starting to look fully priced, especially after a strong run? This article breaks that question down in plain terms. The stock has recently posted a 6.8% return year to date and 20.2% over the last year, with shorter term moves of 1.9% over 30 days and a slight 0.1% decline over 7 days that may have caught your attention. Recent news coverage has focused on Labcorp's position within the broader healthcare sector,...

Event driven snapshot of GE HealthCare Technologies stock GE HealthCare Technologies (GEHC) has been drawing attention after recent share price moves, with the stock up about 7.1% over the past week and 5.5% over the past month, while showing a 12.5% decline over the past 3 months. See our latest analysis for GE HealthCare Technologies. At a share price of $74.67, GE HealthCare Technologies has seen short term momentum soften compared with earlier weakness, with a 1 year total shareholder...

If you are wondering whether HP at around US$18.99 is a bargain or a value trap, the key is to understand what the current share price actually reflects about the business. Over the past week the stock is up 2.0%, while the 30 day return sits near 0.3%, set against a year to date return of about 14.2% decline and a 16.0% decline over the last year. These price moves sit against a backdrop where HP continues to attract attention as a large established tech name, with ongoing interest in how...

If you are wondering whether Bristol-Myers Squibb is attractively priced or already fully valued, the stock's recent moves and current fundamentals give you a lot to weigh up. The share price most recently closed at US$58.08, with returns of 0.7% over 7 days, a 1.7% decline over 30 days, 8.6% year to date and 22.0% over 1 year, while the 3 year and 5 year returns sit at a 5.0% decline and 7.5% respectively. Recent headlines around Bristol-Myers Squibb have continued to focus on its position...

Markel Group (MKL) heads into its 20 May 2026 annual meeting with shareholder proposals on special meeting rights and environmental risk reporting, and a board recommendation that investors vote against both items. See our latest analysis for Markel Group. Those governance debates are landing at a time when Markel Group’s share price has pulled back on a 90 day and year to date basis, even as its 1 year total shareholder return of 10.39% and 3 year total shareholder return of 45.06% reflect a...

Louisiana-Pacific (LPX) shares recently closed at $75.23. The total return over the past 3 months showed an 18.2% decline, and the year-to-date return was 8% lower for investors tracking performance. See our latest analysis for Louisiana-Pacific. Recent share price action has been choppy, with a 7.6% 7 day share price return sitting against a 90 day share price return decline of 18.2% and a weaker 1 year total shareholder return of 11.1%. If Louisiana-Pacific has you reassessing where to find...